Ambev (NYSE:ABEV - Get Free Report) is expected to issue its Q3 2025 results before the market opens on Thursday, October 30th. Analysts expect the company to announce earnings of $0.04 per share and revenue of $3.9726 billion for the quarter. Parties can find conference call details on the company's upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Thursday, October 30, 2025 at 11:30 AM ET.
Ambev (NYSE:ABEV - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $0.03 earnings per share for the quarter, meeting analysts' consensus estimates of $0.03. Ambev had a net margin of 16.18% and a return on equity of 15.39%. The company had revenue of $3.59 billion during the quarter, compared to analysts' expectations of $21.84 billion. On average, analysts expect Ambev to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Ambev Stock Performance
Shares of ABEV stock opened at $2.20 on Thursday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.80 and a current ratio of 1.11. Ambev has a one year low of $1.76 and a one year high of $2.63. The company's 50-day simple moving average is $2.23 and its 200-day simple moving average is $2.34. The stock has a market capitalization of $34.59 billion, a price-to-earnings ratio of 13.72, a PEG ratio of 2.23 and a beta of 0.85.
Ambev Increases Dividend
The business also recently declared a -- dividend, which was paid on Tuesday, October 14th. Stockholders of record on Monday, August 11th were given a dividend of $0.023 per share. The ex-dividend date of this dividend was Monday, August 11th. This is a positive change from Ambev's previous -- dividend of $0.02. This represents a dividend yield of 660.0%. Ambev's dividend payout ratio is 31.25%.
Institutional Investors Weigh In On Ambev
Large investors have recently made changes to their positions in the company. Integrated Wealth Concepts LLC acquired a new stake in shares of Ambev in the first quarter valued at approximately $26,000. EverSource Wealth Advisors LLC increased its stake in shares of Ambev by 2,224.1% in the second quarter. EverSource Wealth Advisors LLC now owns 12,248 shares of the company's stock valued at $30,000 after purchasing an additional 11,721 shares during the period. Focus Partners Wealth acquired a new stake in shares of Ambev in the first quarter valued at approximately $33,000. Marex Group plc acquired a new stake in shares of Ambev in the second quarter valued at approximately $48,000. Finally, Benjamin Edwards Inc. acquired a new stake in shares of Ambev in the second quarter valued at approximately $54,000. Institutional investors and hedge funds own 8.13% of the company's stock.
Analysts Set New Price Targets
ABEV has been the topic of several research analyst reports. HSBC reaffirmed a "hold" rating on shares of Ambev in a research report on Friday, August 1st. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Ambev in a research report on Wednesday, October 8th. Zacks Research raised shares of Ambev from a "strong sell" rating to a "hold" rating in a research report on Tuesday, September 30th. Hsbc Global Res raised shares of Ambev to a "hold" rating in a research report on Friday, August 1st. Finally, UBS Group cut their target price on shares of Ambev from $2.50 to $2.20 and set a "neutral" rating on the stock in a report on Wednesday, August 20th. Eight equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Reduce" and an average target price of $2.35.
Check Out Our Latest Analysis on Ambev
About Ambev
(
Get Free Report)
Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ambev, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.
While Ambev currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
